TNF and colitis: 7-hydroxyfrullanolide was also tested in different animal inflammation models, in which oral administration dose-dependently diminished the induced and spontaneous production of TNF-α along with IL-6 in a BALB/c ear edema model and in DSS-induced colitis in mice [65].